Current Neuropharmacology
Title: Erratum
Volume: 5 Issue: 3
Export Options
About this article
Cite this article as:
Erratum, Current Neuropharmacology 2007; 5 (3) . https://dx.doi.org/10.2174/157015907781695892
DOI https://dx.doi.org/10.2174/157015907781695892 |
Print ISSN 1570-159X |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6190 |
14
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Ageing and Nutritional Therapy Adherence in Type 2 Diabetes
Current Diabetes Reviews Dopaminergic and Noradrenergic Contributions to Functionality in ADHD: The Role of Methylphenidate
Current Neuropharmacology Heterocyclic Amaryllidaceae Alkaloids: Biosynthesis and Pharmacological Applications
Current Topics in Medicinal Chemistry Role of Neurotrophic Factors in Parkinson's Disease
Current Pharmaceutical Design 6-Membered Pyrrololactams: An Overview of Current Synthetic Approaches to their Preparation
Current Organic Chemistry Importance of P-gp PET Imaging in Pharmacology
Current Pharmaceutical Design Cyclophilin A: A Predictive Biomarker of Carotid Stenosis in Cerebral Ischemic Stroke
Current Neurovascular Research Immunotherapy and Targeted Therapy Combinations in Renal Cancer
Current Clinical Pharmacology Synergism between Methanol Extract of Pine Needles and Antibiotics Against Oral Pathogens
Anti-Infective Agents Current Developments for the Diagnosis and Treatment of Irritable Bowel Syndrome
Current Pharmaceutical Design Editorial (Thematic Issue:“Prion; Mechanism and Function”)
Current Pharmaceutical Biotechnology Subject Index to Volume 10
Current Pharmaceutical Design Stress, Depression and Antidepressant Treatment Options in Patients Suffering from Multiple Sclerosis
Current Pharmaceutical Design Isolation of a New Trypsin Inhibitor from the Faba Bean (Vicia faba cv. Giza 843) with Potential Medicinal Applications
Protein & Peptide Letters Quantitative Enzymology
Current Enzyme Inhibition Patent Selections
Recent Patents on Chemical Engineering Premature Aging in Fibromyalgia
Current Aging Science PREPL, a Prolyl Endopeptidase-Like Enzyme by Name Only? – Lessons from Patients
CNS & Neurological Disorders - Drug Targets Dopaminergic Neuroprotection with Atremorine in Parkinson´s Disease
Current Medicinal Chemistry Synthetic Applications Based on Dehydrogenative Alcohol Activation Catalyzed by Mn-, Fe and Co-Complexes
Current Organic Chemistry